ArticleFrontiers in immunology2018

Immunomodulatory Drugs in the Context of Autologous Hematopoietic Stem Cell Transplantation Associate With Reduced Pro-tumor T Cell Subsets in Multiple Myeloma.

Giulia Di Lullo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.